Slocum, Gordon & CO LLP Eli Lilly & CO Transaction History
Slocum, Gordon & CO LLP
- $129 Million
- Q2 2024
A detailed history of Slocum, Gordon & CO LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Slocum, Gordon & CO LLP holds 10 shares of LLY stock, worth $9,237. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10Holding current value
$9,237% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding LLY
# of Institutions
3,868Shares Held
751MCall Options Held
6.34MPut Options Held
7.97M-
Lilly Endowment Inc Indianapolis, IN97.4MShares$89.9 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$68.2 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$60.8 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$47.5 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$31.3 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $878B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...